Cambio - Excellence in Molecular Biology

Enzymes for Molecular Biology

Enzymes for Molecular Biology: Enzymes for Molecular Biology

RNA 5’ Polyphosphatase

An enzyme patented by CELLSCRIPT™ that converts 5’-triphosphate and 5’-diphosphate RNA to 5’-monophosphate RNA. It can be used for applications such as removing uncapped RNA from mRNA preparations (with XRN1) and to prep substrates for circRNA workflows.

CellScript

Catalogue No.DescriptionPack SizePriceQty
R5P2601400RNA 5’ Polyphosphatase400 U POA Quantity Add to Order

Description

RNA 5’ Polyphosphatase

 

Product Description:

RNA 5' Polyphosphatase is a patented enzyme that catalyzes the removal of γ and β phosphate groups from 5'-triphosphorylated and 5'-diphosphorylated RNA resulting in 5'-monophosphorylated RNA. Capped RNA is not a substrate for the enzyme.

RNA 5' Polyphosphatase can be used for the following applications:

  • Removal of uncapped RNA from an mRNA preparation, in conjunction with XRN1 treatment.
  • 5' end RNA substrate preparation for RNA Ligase-based circularization reactions.
  • 5' end RNA substrate preparation for T4 RNA Ligase-based reactions (end tagging).

RNA 5' Polyphosphatase is active on nucleoside triphosphates and is inhibited by inorganic phosphate, a natural reaction product. Removal of unincorporated nucleotides and inorganic phosphates from completed transcription reactions is recommended for full enzymatic activity on the intended RNA substrate.

  • Catalyzes the removal of γ and β phosphate groups from
    5'-triphosphorylated and 5'- diphosphorylated RNA, resulting in
    5’-monophosphorylated RNA.
  • Two protocols provided for easy- and hard-to-treat samples.
  • Use in conjunction with XRN1 to remove uncapped RNA from
    mRNA preparations.
  • Use for 5’ end RNA substrate preparation for
    T4 RNA Ligase-based reactions.

Product is for research use only (RUO)

Product performance

 

 

Figure 1. Two different 5'-triphosphate primary transcript RNAs were treated with RNA 5' Polyphosphatase using the Standard Protocol (no pre heat denaturation step used). After the 30 minute incubation, additional MgCl2 (for buffer compatibility) and XRN1 (5'-monophosphate-dependent exonuclease) was added to the reaction to digest the RNA 5' Polyphosphatase reaction product. Following treatment with RNA 5’ Polyphosphatase and XRN1, the 1.85-kb RNA (lane 2) and 0.92-kb RNA (lane 4) were digested.

 

Figure 2. A 1.57-kb 5'-triphosphate primary transcript RNA containing stable secondary structure on the 5' end was treated with RNA 5' Polyphosphatase using the Alternate Protocol (pre heat denaturation step used). After the 30 minute incubation, additional MgCl2 (for buffer compatibility) and XRN1 (5'-monophosphate-dependent exonuclease) was added to the reaction to digest the RNA 5' Polyphosphatase reaction product. Heat denaturation prior to RNA 5’ Polyphosphatase and XRN1 treatment improved reaction efficiency (lane 6).

 

Components Volume
RNA 5' Polyphosphatase, 20 U/µl
in 50% glycerol, 50 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 0.1 mM EDTA and 0.1% Triton® X-100.
20 µl
10X RNA 5' Polyphosphatase Reaction Buffer
0.5 M HEPES-KOH, pH 7.5, 1 M NaCl, 10 mM EDTA, 1% β-mercaptoethanol, and 0.1% Triton X-100.
100 µl

 

Manual

SDS

Product Flyer

 

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200